Abstract
Accurate detection of viable Leishmania parasites is critical for evaluating visceral leishmaniasis (VL) treatment response at an early timepoint. We compared the decay of kinetoplast DNA (kDNA) and spliced-leader RNA (SL-RNA) in vitro, in vivo, and in a VL patient cohort. An optimized combination of blood preservation and nucleic acid extraction improved efficiency for both targets. SL-RNA degraded more rapidly during treatment than kDNA, and correlated better with microscopic examination. SL-RNA quantitative polymerase chain reaction emerges as a superior method for dynamic monitoring of viable Leishmania parasites. It enables individualized treatment monitoring for improved prognoses and has potential as an early surrogate endpoint in clinical trials.
Original language | English |
---|---|
Journal | Journal of Infectious Diseases |
Number of pages | 5 |
ISSN | 0022-1899 |
DOIs | |
Publication status | E-pub ahead of print - 2024 |
Keywords
- PCR
- Diagnostics
- Leishmaniasis
- Surrogate marker
- Treatment response